Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3849000 | American Journal of Kidney Diseases | 2012 | 10 Pages |
Abstract
Use of a combination of 3 biocompatible PD fluids for 12 months compared with conventional PD fluid did not affect RRF, but was associated with better preservation of daily urine volume. The biocompatible PD fluids also lead to changes in small-solute transport and an increase in dialysate cancer antigen 125, IL-6, adiponectin, and systemic adiponectin levels, but have no effect on systemic inflammatory response. The clinical significance of these changes, while of great interest, remains to be determined by further studies.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Sing Leung MD, PhD, FRCP, Susan PhD, Andrew BSc, Kui Man MBBS, FRCP, Kwok Lung MBBS, FRCP, Kin Shing MBBS, FRCP, Chun Sang MBBS, FRCP, Tak Cheung MBBS, FRCP, Wai Kei MBBS, FRCP, Yiu Wing MBBS, FRCP, Flora RN, Colin BSc, Tak Mao MD, FRCP,